International investor influx in South East Asia1 Mar 2018
ASEAN Economic Community and relaxed rules on foreign ownership driving increases in international investment and partnerships.
Geopolitical stability, gradually rising living standards and the introduction of universal healthcare systems is fuelling investor interest across South East Asia – particularly for Indonesia, which is home to the largest and fastest growing market.
The recent rule changes to foreign ownership in Indonesia – increasing from 75% to 100% – have meant that international pharma companies are looking for both regional partners and acquisition targets for a local manufacturing base. This, in turn, has increased the capital access for manufacturers across the region as investors look to ‘get in early’ amongst the best facilities before a potential round of consolidation and an increased interest from multinational pharma companies.
These improving regional conditions are reflected at CPhI South East Asia (27-29 March 2018), which returns to the Jakarta International Expo (JIExpo) in Indonesia for its seventh edition – where there has been an increase in domestic, regional and multinational manufacturers attending. In total, 41 countries and over 5000 attendees will be present, with 260 exhibitors coming from 22 countries and an increasingly diverse range of industries.
“It’s a very competitive market at present and whilst there is strong investment coming in, the middle-tier of manufacturers in Indonesia are competing to acquire increased scale and our visitors are looking to secure the most robust supply chains that can help them sustain growth in this expanding market. So, although the outlook for growth is very optimistic, it remains a crucial time to build the right supply chain infrastructure and partners,” commented Chris Kilbee, Group Director, Pharma at UBM.
Vietnam- and Philippines-based pharma companies are also regionalising their approach to sales, with ASEAN economic community and the acceleration of local health insurance schemes contributing to confidence. Generics in both markets are reportedly benefiting, and sales are expanding at just under 10% in the Philippines, which is forecast to reach $7.9 billion by the close of the year.
Kilbee added: “What we also see is a regional network being built. With increased visitors from Thailand, the region’s second-largest market, as well as investors and visitors from Singapore – another regional distribution and investment hub.”
In response to the increased regional foreign direct investment, CPhI is running an invitation-only Investment Forum to match the key international investors with top-tier pharma companies now looking for reliable partners.
In fact, 2018 also sees the introduction of LABworld South East Asia, a new co-located zone to support the laboratory, analytical and biotech equipment industry, which has expanded quickly as companies in the region look to adopt international standards. The Indonesian Institute of Sciences (LIPI) states there are only 500 metrology laboratories and 120 calibration laboratories located in the country – low by regional standards – highlighting another key infrastructure gentrification underway.
The event will also co-locate this year with P-MEC, InnoPack, and the returning ICSE and Health Ingredients South East Asia. This year will welcome the best pharma ingredients professionals, packaging experts, machinery providers and contract manufacturing, as well as nutraceutical companies from across the region – facilitating a strong collaboration between the health and pharma industries.
Dra Maura Linda Sitanggang, PhD Director General of Pharmaceutical Services and Health Devices Ministry of Health, Republic of Indonesia, commented on the event’s role in advancing the pharma industry: “CPhI SEA exhibition is the central forum for the pharmaceutical industry to see the prospects of innovation trends in pharmaceutical raw materials development, packaging materials and production technology.”
Experts warn trade and patent changes could increase healthcare cost by $100bn over next 5 years
18 Sep 2018
China is harmonizing to ICH standards at feverish pace and will force poor quality manufacturers out of market.Read more
Bio processing and manufacturing league table ranks US top and China bottom
3 Sep 2018
US, Germany and Japan revealed as tier one nations in all categories with Sweden ranking the best of the rest.Read more
Innovation "hindered by regulators"
27 Aug 2018
CPhI Annual Report expert sees CDMOs as potentially a source of process innovation but warns both regulator and license holders need to move past regulatory diktats.Read more
Middle East and Africa pharma economy to reach US$38.8 billion by 2021
17 Aug 2018
CPhI Middle East & Africa opens in Abu Dhabi as finished dosage formulations expand quickly, driven by government reforms to further increase local manufacturing.Read more
South Korea's finished drug market growth driven by generics
16 Jul 2018
FDF launches at CPhI Korea as country set to become regional hub.Read more
CPhI Worldwide opens entries for 15th Annual Pharma Awards
5 Jul 2018
Winners will be announced live at the Gala Ceremony in Madrid with over 500 of Pharma’s top executives.Read more
I Holland woos exhibition visitors with new tabletting technologies
28 Jun 2018
Company's Wear Indicator Layer attracts the most attention.Read more
Ingredients to improve bioprocess manufacturing efficiency
27 Jun 2018
Experts warn bio industry needs to do more to create a sustainable pipeline of talent.Read more
Collaboration facilitates continuous manufacturing
14 Jun 2018
Companies working together to help the pharmaceutical industry overcome the different challenges involved in adopting continuous manufacturing.Read more
Attendance rise sees CPhI & P-MEC India 2018 move to Indian capital
12 Jun 2018
The India Expo Mart brings the event closer to Indian regulatory and legislative hub and will encourage international audiences.Read more
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation